Repligen sees FY24 adjusted EPS $1.50-$1.58, consensus $1.43 Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> ...

The independent broker-dealer's latest partner firm, formerly with Cadaret Grant and its acquirer LPL, expects substantial benefits as it streamlines its operations.

A lottery player won $50,000 playing Powerball in Massachusetts on Monday. The winning numbers for the Powerball drawing on ...

WALTHAM, Mass. and BOULDER, Colo., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined ...

Third quarter reported revenue of $155 million, an increase of 10% year-over-yearCDMO revenue and orders both up ~20% year-over-yearOverall order ...

Repligen Corporation, established in 1981 and headquartered in Waltham, Massachusetts, is a global life sciences company ...

Initiated the Phase 2 MoonStone trial, a Phase 2, multicenter, randomized, double-blind, placebo-controlled trial, to evaluate the efficacy and safety of obexelimab in patients with Relapsing Multiple ...

WALTHAM, Mass. (AP) — WALTHAM, Mass. (AP) — Repligen Corp. (RGEN) on Tuesday reported a loss of $653,000 in its third quarter. On a per-share basis, the Waltham, Massachusetts-based company said it ...

Thermo Fisher Scientific has signed an agreement with German molecular genetics company Mainz Biomed, the developer of ...

Megan Sexton is a veterinary technician in the Army and has served all over the country. Chris Sexton is a veteran himself, and so this wasn't the first time the couple had shipped a car. But it was ...